Alzheimer’s DBS trial evokes vivid memories
In The Conversation, Dr. Wissam Deeb explains an unexpected result in a Alzheimer's trial using DBS, and what it could mean.
All Posts by
In The Conversation, Dr. Wissam Deeb explains an unexpected result in a Alzheimer's trial using DBS, and what it could mean.
Examining the role of NMDA receptor hypofunction and redox sensitivity of hippocampal synaptic transmission during aging.
Dr. Wissam Deeb and researcher partners reveal new findings that could advance our understanding of human memory.
Boosted by matching funds from the MBI, the Brooks/Hagood scholarship supports young neuroscientists at UF.
In The Conversation, Drs. Steven DeKosky and Todd Golde discuss the progress and challenges of Alzheimer’s diagnostics.
In the Conversation, Dr. Steven DeKosky weighs in on a new report discouraging the use of dietary supplements to prevent cognitive decline, dementia or Alzheimer's.
In a new eLife article, UF neuroscientists examine brain mechanisms involved with the ability to delay gratification in older and younger adults.
In the journal Neuron, Dr. Golde highlights the promise and challenges of a possible path to treat Alzheimer’s disease and other neurodegenerative disorders.
A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more: